LPL Financial
CRL icon

LPL Financial’s Charles River Laboratories CRL Stock Holding History

LPL Financial’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.41M Sell
23,851
-2,150
-8% -$383K ﹤0.01% 2722
2026
Q1 		$4.49M Sell
26,001
-1,467
-5% -$272K ﹤0.01% 2725
2025
Q4 		$5.48M Buy
27,468
+629
+2% +$114K ﹤0.01% 2454
2025
Q3 		$4.2M Sell
26,839
-1,978
-7% -$314K ﹤0.01% 2628
2025
Q2 		$4.37M Sell
28,817
-11,253
-28% -$1.5M ﹤0.01% 2425
2025
Q1 		$5.86M Sell
40,070
-6,872
-15% -$1.15M ﹤0.01% 2017
2024
Q4 		$8.45M Sell
46,942
-1,229
-3% -$237K ﹤0.01% 1660
2024
Q3 		$9.49M Buy
48,171
+5,458
+13% +$1.13M ﹤0.01% 1500
2024
Q2 		$8.82M Buy
42,713
+1,418
+3% +$321K ﹤0.01% 1459
2024
Q1 		$11.2M Buy
41,295
+617
+2% +$147K 0.01% 1258
2023
Q4 		$9.62M Buy
40,678
+2,329
+6% +$458K 0.01% 1282
2023
Q3 		$7.5M Buy
38,349
+4,856
+14% +$997K 0.01% 1337
2023
Q2 		$7.04M Buy
33,493
+4,540
+16% +$903K 0.01% 1373
2023
Q1 		$5.84M Buy
28,953
+4,785
+20% +$1.08M ﹤0.01% 1411
2022
Q4 		$5.28M Buy
24,168
+2,750
+13% +$601K ﹤0.01% 1417
2022
Q3 		$4.21M Buy
21,418
+3,854
+22% +$832K ﹤0.01% 1493
2022
Q2 		$3.76M Buy
17,564
+2,025
+13% +$495K ﹤0.01% 1582
2022
Q1 		$4.41M Buy
15,539
+966
+7% +$298K ﹤0.01% 1524
2021
Q4 		$5.49M Buy
14,573
+5,319
+57% +$2.07M ﹤0.01% 1398
2021
Q3 		$3.82M Buy
9,254
+313
+4% +$130K ﹤0.01% 1572
2021
Q2 		$3.31M Buy
8,941
+902
+11% +$301K ﹤0.01% 1629
2021
Q1 		$2.33M Sell
8,039
-380
-5% -$106K ﹤0.01% 1732
2020
Q4 		$2.1M Buy
8,419
+550
+7% +$131K ﹤0.01% 1644
2020
Q3 		$1.78M Buy
7,869
+1,206
+18% +$250K ﹤0.01% 1529
2020
Q2 		$1.16M Buy
6,663
+870
+15% +$139K ﹤0.01% 1722
2020
Q1 		$731K Sell
5,793
-24
-0.4% -$3.6K ﹤0.01% 1831
2019
Q4 		$888K Sell
5,817
-608
-9% -$84.2K ﹤0.01% 1930
2019
Q3 		$850K Sell
6,425
-1,712
-21% -$230K ﹤0.01% 1849
2019
Q2 		$1.16M Buy
8,137
+4,136
+103% +$561K ﹤0.01% 1626
2019
Q1 		$582K Sell
4,001
-5
-0.1% -$657 ﹤0.01% 2094
2018
Q4 		$453K Sell
4,006
-594
-13% -$74.4K ﹤0.01% 2113
2018
Q3 		$619K Sell
4,600
-1,443
-24% -$178K ﹤0.01% 2070
2018
Q2 		$678K Sell
6,043
-159
-3% -$17.2K ﹤0.01% 1936
2018
Q1 		$661K Sell
6,202
-151
-2% -$16.3K ﹤0.01% 1912
2017
Q4 		$696K Sell
6,353
-268
-4% -$29.2K ﹤0.01% 1781
2017
Q3 		$734K Buy
6,621
+2,653
+67% +$273K ﹤0.01% 1656
2017
Q2 		$394K Buy
3,968
+245
+7% +$22.6K ﹤0.01% 2062
2017
Q1 		$333K Buy
+3,723
New +$316K ﹤0.01% 2123
2016
Q4 		– Sell
-2,559
Closed -$213K – 2695
2016
Q3 		$213K Sell
2,559
-1,658
-39% -$139K ﹤0.01% 2369
2016
Q2 		$351K Buy
+4,217
New +$347K ﹤0.01% 1957
2015
Q1 		– Sell
-4,501
Closed -$286K – 2802
2014
Q4 		$286K Sell
4,501
-29
-0.6% -$1.82K ﹤0.01% 2203
2014
Q3 		$268K Buy
4,530
+95
+2% +$5.43K ﹤0.01% 2260
2014
Q2 		$237K Sell
4,435
-1,863
-30% -$102K ﹤0.01% 2372
2014
Q1 		$380K Sell
6,298
-299
-5% -$17.4K ﹤0.01% 1969
2013
Q4 		$350K Buy
6,597
+136
+2% +$6.83K ﹤0.01% 1996
2013
Q3 		$299K Sell
6,461
-13
-0.2% -$597 ﹤0.01% 2004
2013
Q2 		$266K Buy
+6,474
New +$277K ﹤0.01% 1994

Other funds holding CRL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

LPL Financial's CRL Position: Q2 2026 in Review

LPL Financial reduced its Charles River Laboratories (CRL) stake by 8.3% in Q2 2026, selling an estimated $383K and leaving 23,851 shares worth $5.41M. The position accounts for ﹤0.01% of the portfolio, ranked #2722.

LPL Financial first reported a position in CRL in Q2 2013 and has held it in 47 quarters since. The position peaked at $11.2M in Q1 2024. 569 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • LPL Financial held 23,851 shares of Charles River Laboratories worth $5.41M as of Q2 2026.
  • LPL Financial sold 2,150 Charles River Laboratories shares in Q2 2026, an estimated $383K.
  • Charles River Laboratories made up ﹤0.01% of LPL Financial's portfolio in Q2 2026, its #2722 holding.
  • LPL Financial first reported a position in Charles River Laboratories in Q2 2013 and has held it in 47 quarters since.
  • LPL Financial's Charles River Laboratories position peaked at $11.2M in Q1 2024.
  • 569 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on LPL Financial's 13F filing for Q2 2026, filed 7 Aug 2026.